Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zeaxanthin as an Adjuvant to Combination Therapy for Treatment of Choroidal Neovascularization (CNV) in Exudative Age Related Macular Degeneration (ARMD)

NCT01527435 is registered in ClinicalTrials.gov with The Retina Center of St. Louis County, PC as lead sponsor.

NCT NCT01527435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01527435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zeaxanthin as an Adjuvant to Combination Therapy for Treatment of Choroidal Neovascularization (CNV) in Exudative Age Related Macular Degeneration (ARMD)
Lead sponsor
The Retina Center of St. Louis County, PC
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
December 31, 2015
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration